CHAPEL HILL -- Bob Young, founder and CEO of the self-publishing site, Lulu.com, will speak at UNC Chapel Hill tonight.
The talk is a part of the event, "Taking on the Giants," will begin at 5:30 p.m. in the Kenan-Flagler Business School's Koury Auditorium and is organized by the MBA Entrepreneurship Club.
Young was also co-founder and former CEO of Red Hat. He founded Lulu.com in 2002.
To register for the free, public event, go to kfbsrsvp.eventbrite.com.
Grant to fund RTI spraying program
DURHAM -- RTI International has received a new $25 million award from the U.S. Agency for International Development to continue its indoor residual spraying program in Kenya, which helps protect people from malaria.
Indoor residual spraying is the spraying of an insecticide on inside walls to kill adult female mosquitoes before they can transmit malaria to another person.
The award is part of a U.S. Malaria Initiative that aims to reduce malaria-related mortality by 50 percent in 15 African countries over five years.
Counter Culture to host tasting
DURHAM -- Counter Culture Coffee will be hosting a coffee tasting Thursday night to benefit SouthWings, a conservation nonprofit based in Asheville.
The tasting, which will also include beer, wine and light hors d'oeuvres, will be hosted at Counter Culture's training center at 4911 South Alston Ave. from 5:30 p.m. to 7:30 p.m.
Counter Culture President and co-founder Brett Smith is a board member of SouthWings. Smith and the organization's executive director, Will Callaway, will discuss SouthWings' work at the event.
The organization provides flights and information from an aerial view to those who want to better understand conservation efforts and ecosystems in the Southeast.
For more information or to RSVP for the coffee tasting, e-mail mark@southwings.org.
Quintiles moves laboratory
DURHAM -- Quintiles has moved its Global Central Laboratory in Japan from Saitama to Tokyo to allow for expansions in the global contract research organization's business in Japan and the Asia-Pacific, the company announced Tuesday.
The new facility has expanded testing capabilities with an initial focus on safety testing. The lab began receiving and testing clinical trial samples on March 1 and has received a certification for diabetes testing.
"The growth of clinical research in Asia-Pacific is driving this move as we continue to reduce complexity and help our customers get new medicines to patients faster," said Alan Ong, vice president and general manager of Quintiles Global Central Laboratories Asia. "We are building on a strong record of high quality and outstanding customer service, and with an expanding test menu, it makes sense to move into new facilities that provide room for growth."
